Merck & Co., Inc. - 07 May 2021 Form 3 Insider Report for Organon & Co. (OGN)

Role
10%+ Owner
Signature
Merck & Co., Inc. /s/ Kelly E.W. Grez, Deputy Corporate Secretary
Issuer symbol
OGN
Transactions as of
07 May 2021
Net transactions value
$0
Form type
3
Filing time
07 May 2021, 17:02:45 UTC
Next filing
04 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OGN Common Stock 100 07 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 3 is being filed in connection with the Securities and Exchange Commission's declaration of effectiveness of the Registration Statement on Form 10 of Organon & Co. ("Organon"), which describes the separation of Organon from Merck & Co., Inc.